Medicare Enrolled

Dr. Donald Miller, M.D.

Rheumatology · Bryn Mawr, PA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
825 OLD LANCASTER RD, Bryn Mawr, PA 19010
6105273800
Registered in NPPES since 2006
NPI: 1376569418 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Miller from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Miller? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Miller

Dr. Donald Miller is a rheumatology specialist in Bryn Mawr, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Miller performed 257,745 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Miller received a total of $15,937 from 63 pharmaceutical and/or device companies across 748 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Miller is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 2% volume in PA $15,937 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
257,745
Medicare services
Top 2% in PA for rheumatology
Not available
Unique patients (not deduplicated)
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Tocilizumab injection (Actemra) 121,200 $5 $15
Certolizumab injection (Cimzia)
An injection of certolizumab pegol administered under the direct supervision of a physician.
94,400 $4 $10
Denosumab injection (Prolia/Xgeva) 13,740 $18 $40
Abatacept infusion (Orencia)
An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered.
12,400 $34 $65
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
9,120 $26 $115
Rituximab injection, 10 mg
Administration of a 10 mg dose of rituximab medication via injection.
2,700 $64 $150
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
929 $12 $50
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
865 $97 $218
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
644 $110 $322
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
437 $69 $143
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
340 $6 $113
Injection, methylprednisolone acetate, 40 mg 207 $6 $20
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
194 $24 $72
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
182 $1 $11
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
72 $58 $149
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
61 $48 $170
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
61 $126 $255
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
44 $13 $55
Flu vaccine, quadrivalent
A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection.
38 $76 $110
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
38 $32 $40
Methylprednisolone injection, up to 125 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg.
29 $4 $25
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
28 $47 $89
Joint fluid aspiration or injection, small joint
Removal of fluid from a small joint or injection of medication into a small joint.
16 $44 $101
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
8.6% high complexity
90.8% medium
0.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$15,937
Total received (2018-2024)
Avg $2,277/year across 7 years
Top 22% in PA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
748
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,555
2023
$3,014
2022
$2,546
2021
$1,561
2020
$1,302
2019
$2,743
2018
$2,215

Payments by company (2024)

ABBVIE INC.
$371
AstraZeneca Pharmaceuticals LP
$328
Amgen Inc.
$227
Novartis Pharmaceuticals Corporation
$191
Alexion Pharmaceuticals, Inc.
$183
ANI Pharmaceuticals, Inc.
$169
Fresenius Kabi USA, LLC
$145
Lilly USA, LLC
$142
Genentech USA, Inc.
$117
GENZYME CORPORATION
$73
PFIZER INC.
$72
Organon Llc
$60
Sandoz Inc.
$60
UCB, Inc.
$57
Radius Health, Inc.
$55
Janssen Biotech, Inc.
$48
SCILEX PHARMACEUTICALS INC.
$43
Boehringer Ingelheim Pharmaceuticals, Inc.
$34
E.R. Squibb & Sons, L.L.C.
$32
GlaxoSmithKline, LLC.
$23
Aurinia Pharma U.S., Inc.
$22
Kyowa Kirin, Inc.
$20
Mallinckrodt Hospital Products Inc.
$18
Fidia Pharma USA Inc.
$18
Kiniksa Pharmaceuticals International, plc
$17
Alvogen Inc
$17
DePuy Synthes Sales Inc.
$15
Top 3 companies account for 36.2% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$2,287
AstraZeneca Pharmaceuticals LP
$1,548
ABBVIE INC.
$943
UCB, Inc.
$918
Novartis Pharmaceuticals Corporation
$889
PFIZER INC.
$833
Janssen Biotech, Inc.
$758
Boehringer Ingelheim Pharmaceuticals, Inc.
$476
Genentech USA, Inc.
$406
Alexion Pharmaceuticals, Inc.
$370
Lilly USA, LLC
$338
ANI Pharmaceuticals, Inc.
$328
AbbVie, Inc.
$326
E.R. Squibb & Sons, L.L.C.
$308
Radius Health, Inc.
$295
Flexion Therapeutics, Inc.
$288
Bayer HealthCare Pharmaceuticals Inc.
$283
GlaxoSmithKline, LLC.
$274
GENZYME CORPORATION
$254
Amarin Pharma Inc.
$250
Mallinckrodt Hospital Products Inc.
$244
Celgene Corporation
$238
Merck Sharp & Dohme Corporation
$211
AbbVie Inc.
$190
Bioventus LLC
$172
Fresenius Kabi USA, LLC
$170
Takeda Pharmaceuticals U.S.A., Inc.
$137
Exeltis, USA Inc.
$134
Sandoz Inc.
$128
DePuy Synthes Sales Inc.
$127
Insmed, Inc.
$125
Paratek Pharmaceuticals, Inc.
$123
Otsuka America Pharmaceutical, Inc.
$120
Actelion Pharmaceuticals US, Inc.
$111
Horizon Therapeutics plc
$111
Shire North American Group Inc
$102
Aurinia Pharma U.S., Inc.
$102
Mallinckrodt Enterprises LLC
$89
Cumberland Pharmaceuticals, Inc.
$83
Hikma Pharmaceuticals USA
$63
Organon Llc
$60
Sobi, Inc
$60
IBSA Pharma Inc.
$56
Mallinckrodt LLC
$51
Organon LLC
$48
Antares Pharma, Inc.
$46
Ultragenyx Pharmaceutical Inc.
$46
SCILEX PHARMACEUTICALS INC.
$43
MEDEXUS PHARMA, INC.
$42
SOBI, INC
$38
Kiniksa Pharmaceuticals, Ltd.
$36
Fidia Pharma USA Inc.
$34
Ironwood Pharmaceuticals, Inc
$30
MEDAC PHARMA, INC.
$28
Ferring Pharmaceuticals Inc.
$28
Horizon Pharma plc
$24
Kyowa Kirin, Inc.
$20
SANOFI-AVENTIS U.S. LLC
$19
Kiniksa Pharmaceuticals International, plc
$17
Alvogen Inc
$17
Celltrion USA Inc.
$14
West-Ward Pharmaceuticals
$14
Mission Pharmacal Company
$12
Top 3 companies account for 30.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · Aimovig · Aquoral · Arcalyst · Arikayce · BENLYSTA · COSENTYX · CYLTEZO · Cimzia · Crysvita · Cryvista · DIFICID · DUZALLO · Durolane · EUFLEXXA · EVENITY · Enbrel · FASENRA · FORTEO · GATTEX · HADLIMA · HUMIRA · HYMOVIS · HYRIMOZ · Humira · IDACIO · ILARIS · INFLECTRA · JARDIANCE · JYNARQUE · KEVZARA · KINERET · KRYSTEXXA · Kerendia · Kineret · LUMIZYME · LUPKYNIS · LYRICA · Licart · MONOVISC · Mitigare · NUCALA · NUZYRA · OFEV · OPSUMIT · ORENCIA · ORTHOVISC · Otezla · Otrexup · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REDITREX · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Repatha · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · SOVUNA · SPEVIGO · STELARA · STRENSIQ · SYNVISC-ONE · Strensiq · TAGRISSO · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · Tavneos · Tirosint · Tyenne · Tymlos · UBRELVY · UPTRAVI · Uloric · Vascepa · XELJANZ · YUFLYMA · ZTLido · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a rheumatology specialist in Bryn Mawr?
Compare rheumatologists in the Bryn Mawr area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists in nearby ZIP areas
178
County median income
$88,576
Nearest hospital to ZIP centroid (approximate)
BRYN MAWR HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Miller is a mixed practice specialist, with above-average Medicare volume (top 2% in PA), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Miller experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Miller performed 121,200 tocilizumab injection (actemra) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Miller receive payments from pharmaceutical companies?
Yes. Dr. Miller received a total of $15,937 from 63 companies across 748 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Miller's costs compare to other rheumatologists in Bryn Mawr?
Dr. Miller's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Miller) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →